AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,392,000 | -34.8% | 62,896 | -61.8% | 0.51% | -33.3% |
| Q2 2021 | $2,136,000 | +6.2% | 164,840 | +6.5% | 0.76% | -11.7% |
| Q1 2021 | $2,011,000 | -18.1% | 154,840 | -12.8% | 0.86% | -22.6% |
| Q4 2020 | $2,455,000 | +23.8% | 177,540 | +31.9% | 1.11% | -4.5% |
| Q3 2020 | $1,983,000 | +6.3% | 134,600 | +17.2% | 1.16% | +14.1% |
| Q2 2020 | $1,866,000 | +1660.4% | 114,810 | +1472.7% | 1.02% | +1420.9% |
| Q1 2020 | $106,000 | -62.5% | 7,300 | -86.2% | 0.07% | -43.7% |
| Q3 2019 | $283,000 | -25.9% | 53,000 | -8.6% | 0.12% | -26.1% |
| Q2 2019 | $382,000 | +11.4% | 58,000 | +10.1% | 0.16% | +17.5% |
| Q1 2019 | $343,000 | – | 52,700 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |